Osteoporosis

Osteoporosis

ACCORDING TO THE WORLD HEALTH ORGANIZATION
OSTEOPOROSIS IS DEFINED AS A SYSTEMIC SKELETAL DISEASE CHARACTERIZED BY LOW BONE DENSITY AND A DISORDER OF BONE MICROARCHITECTURE, LEADING TO A REDUCTION IN BONE QUALITY AND BONE INCREASED FRAGILITY.

According to the World Health Organization, osteoporosis is defined as a systemic disease of the skeleton characterized by low bone density and a disorder of the microarchitecture of bone tissue, leading to a decrease in bone quality and increased bone fragility. Osteoporosis is one of the so-called diseases of civilisation and represents one of the most serious diseases with a widespread impact on the population. In developed countries, it affects about 8% of the population.
The development of osteoporosis is often asymptomatic and is only manifested by serious complications, including compression fractures of the vertebrae, femoral neck and forearm. This is why it is also called the "silent thief". In this sense, osteoporosis is similar to such diseases as hypercholesterolemia or hypertension. Fractures most often affect the population after the age of 60. Up to 20% of patients die within the first year after the event and up to 50% are physically disabled or directly dependent on social services later in life.

Osteoporosis is divided into:

primary - in women it is much more common and is related to the loss of the protective function of estrogens after the transition, in men it is related to age
secondary - related to certain diseases or the use of certain medications

Factors affecting the osteoporotic process

UNCONTROLLABL

  • genetic factors (70%)
  • gender - women are affected much more often
  • ethnic group - white race more affected
  • age - higher age groups

 OPTIONAL

  • Adequate calcium intake during childhood and adulthood, especially during pregnancy, breastfeeding and after transition
  • a nutritionally and nutritionally sound diet
  • sufficient vitamin D throughout life (lack of sun exposure, reduced enzyme activity in old age)
  • active lifestyle with adequate exercise, lifelong non-smoking, limited alcohol, coffee, phosphates in beverages and diet

 Diseases or conditions predisposing to osteoporosis:

  • Thyroid and parathyroid hyperfunction (higher thyroxine and parathyroid hormone levels)
  • chronic liver and kidney disease
  • chronic obstructive pulmonary disease
  • certain blood diseases (multiple myeloma... )
  • rheumatoid arthritis
  • premature menopause, menstrual cycle disorders with hyperprolactinemia and estrogen deficiency
  • diseases limiting mobility

Risky drugs:

  • Corticosteroids (prednisone, dexamethasone)
  • drugs that reduce blood clotting - anticoagulants (heparin, warfarin)
  • drugs that suppress immune reactions - immunosuppressants
  • extremely low doses of hormonal contraceptives during skeletal development 

Diagnostics
Quantitative ultrasound densitometry is the most accessible basic examination for diagnosis. Highlights and most accurate method is then two-photon X-ray absorptiometry - DXA, which measures the predilection sites (wrist, hip and lower thoracic and lumbar spine). A conventional X-ray will reveal osteoporosis with up to 30% loss of bone mineral density.


Classical treatment
Calcium supplementation in the range of 500 to 1,000 mg per day (calcium carbonate or citrate) is essential. The problem is decreasing absorption with age and sometimes poor digestive tolerability. Further management involves vitamin D supplementation at a daily dose of 400-800 IU. In postmenopausal women, where the cause of the bone thinning process is a decline in estrogen levels, it is then hormone replacement therapy with estrogens, which is often well effective but has its risks. Among the newer agents used are the so-called selective estrogen receptor modulators (raloxifene - Evista), which do not have some of the risks of conventional estrogens. Other effective drugs are the so-called bisphosphonates (alendronate - Fosamax, risedronate - Actonel), which slow down bone resorption. Their disadvantage is irritation of the esophagus and stomach with the possibility of their damage.

Bone density is also improved and pain-relieving by calcitonin hormone (thyroid C-cell hormone). Salmon calcitonin is used in the form of a nasal spray - Miacalcic.

Parathyroid hormone in an anabolic dose, strontium salts and growth hormone also have a stimulating effect on bone density.

 

Osteoporosis and Energy preparations
Energy products are a gentle alternative to conventional medicine and reduce the risk of sometimes serious side effects of drugs. They use the principles of bioinformation and bioresonance and therefore show much better efficacy than simple supplements. The basis of the whole procedure, which positively affects bone remodelling, is the harmonising effect on the kidneys.

Main products

Renol - herbal concentrate for strengthening and regeneration of kidneys and also tissues that fall under their influence (bones, teeth, hair). Since it
in osteopenia or osteoporosis, the initial dosage of this preparation should be chosen with caution (due to the possibility of a reverse reaction), starting sometimes with 1 drop 3 times a day; gradually increase the dose. Adherence to a drinking regime is an absolute necessity. Drink pure water; beverages carbonated with C02 or chemically modified are inappropriate.
In order to increase the regenerative effect of the preparation, it is advisable to apply Artrin-herbal bioinformation cream at the same time on the acupuncture path of the kidneys and bladder, where it stimulates the kidneys in the area around the ankles and relieves pain around the spine.
For calcium supplementation (but also other elements important for bone metabolism) we use Fytomineral - a solution of colloidal elements with an absorption rate of 98%, which represents a huge potential for fast and effective action, even in elderly patients.
Skeletin - a bioinformation preparation containing cuttlebone, collagen, manganese, fish oil, nettle and rosehip extract. It supplies bones with calcium and other elements in a bioavailable form, vitamin D and also collagen, which has a beneficial effect on articular cartilage. As a result, it also helps with arthrosis of the joints, which often accompanies osteoporosis. It is suitable for more permanent replacement.

 

 

Complementary products
We take advantage of the phenomenon of absorption of substances through the skin and mucous membranes when applying baths and toothpaste.

Bitermal - salt from the Podhájská spring, obtained by a gentle technological process, which has a similar composition to the water from the Dead Sea.
Balneol - a humate bath with excellent relaxing and pain-relieving effect.
Silix - a bio-information preparation for oral hygiene containing salts from Podhajska and herbal extracts.

In secondary forms of osteoporosis, it is necessary to influence the underlying disease with the help of Pentagram preparations. For example Gynex or Regalen
for thyroid and parathyroid diseases, Regalen for liver diseases, Vironal for lung diseases, Korolen for blood diseases or rheumatoid arthritis.

An absolute necessity in the prevention and treatment of osteoporosis is exercise, preferably walking and hiking. An important goal is prevention and treatment in postmenopausal women where the disease process is asymptomatic.
Regenerative treatment may also cause a temporary deterioration of the condition, when a so-called reverse reaction occurs. Symptoms of past illnesses may reappear. This is a sign of a well ongoing regeneration and should be viewed as such.

 
Brochure Osteoporosis prepared by MUDr. Bohdan Haltmar

Articolul precedent Următorul